JFNCX: Janus Henderson Global Life Sciences C

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

JFNCX Janus Henderson Global Life Sciences C

  • Fund
  • JFNCX
  • Price as of: Oct 16, 2019
  • $49.32 - $0.05 - 0.10%
  • Primary Category
  • Uncategorized

JFNCX - Profile

Vitals

  • YTD Return 8.7%
  • 3 Yr Annualized Return 4.1%
  • 5 Yr Annualized Return 0.7%
  • Net Assets $3.61 B
  • Holdings in Top 10 29.0%

52 WEEK LOW AND HIGH

$49.32
$42.59
$57.94

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.75%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 46.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$2,500

IRA

N/A

Fund Classification

PRIMARY CATEGORY

Uncategorized
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 8.7%
  • 3 Yr Annualized Total Return 9.7%
  • 5 Yr Annualized Total Return 8.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.74%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Janus Henderson Global Life Sciences Fund
  • Fund Family Name Janus Henderson
  • Inception Date Jul 06, 2009
  • Shares Outstanding N/A
  • Share Class C
  • Currency USD
  • Domiciled Country United States
  • Manager Andrew Acker

JFNCX - Fund Company Quick Screens

JFNCX - Performance

Return Ranking - Trailing

Period JFNCX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.7% -3.8% 16.5% 52.99%
1 Yr -14.4% -27.6% 2.7% 80.34%
3 Yr 4.1%* -15.3% 15.2% 42.20%
5 Yr 0.7%* -10.4% 12.6% 47.06%
10 Yr 9.3%* -2.7% 16.3% 41.86%

* Annualized


Return Ranking - Calendar

Period JFNCX Return Category Return Low Category Return High Rank in Category (%)
2018 -9.9% -25.3% 21.5% 70.27%
2017 20.3% -10.8% 43.9% 38.53%
2016 -14.1% -31.6% 6.9% 46.23%
2015 -2.0% -20.4% 13.8% 51.46%
2014 20.4% -5.8% 31.5% 32.29%

Total Return Ranking - Trailing

Period JFNCX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.7% -3.8% 16.5% 52.99%
1 Yr -2.0% -27.6% 2.7% 16.24%
3 Yr 9.7%* -15.3% 17.3% 20.18%
5 Yr 8.0%* -10.4% 18.1% 18.63%
10 Yr 14.6%* -2.7% 16.7% 24.42%

* Annualized


Total Return Ranking - Calendar

Period JFNCX Return Category Return Low Category Return High Rank in Category (%)
2018 3.2% -25.3% 22.2% 9.01%
2017 21.5% -10.8% 45.8% 44.04%
2016 -13.2% -26.4% 8.7% 55.66%
2015 7.2% -16.6% 15.2% 38.83%
2014 34.0% -5.8% 36.7% 12.50%

NAV & Total Return History

JFNCX - Holdings

Concentration Analysis

JFNCX Category Low Category High JFNCX % Rank
Net Assets 3.61 B 2.52 M 42.7 B 18.11%
Number of Holdings 95 28 390 40.16%
Net Assets in Top 10 1.15 B 807 K 17.9 B 22.05%
Weighting of Top 10 29.00% 20.8% 76.5% 93.70%

Top 10 Holdings

  1. Merck & Co Inc 4.29%

  2. Novartis AG ADR 3.44%

  3. Abbott Laboratories 3.09%

  4. UnitedHealth Group Inc 2.79%

  5. Thermo Fisher Scientific Inc 2.79%

  6. AstraZeneca PLC 2.75%

  7. Takeda Pharmaceutical Co Ltd 2.67%

  8. Anthem Inc 2.58%

  9. Boston Scientific Corp 2.35%

  10. Humana Inc 2.26%


Asset Allocation

Weighting Return Low Return High JFNCX % Rank
Stocks
97.11% 90.21% 103.54% 63.78%
Other
1.67% -27.41% 3.81% 8.66%
Cash
0.88% 0.00% 9.79% 65.35%
Convertible Bonds
0.18% 0.00% 1.54% 5.51%
Bonds
0.16% 0.00% 20.60% 5.51%
Preferred Stocks
0.00% 0.00% 2.60% 52.76%

Stock Sector Breakdown

Weighting Return Low Return High JFNCX % Rank
Healthcare
95.63% 56.60% 99.76% 38.58%
Technology
1.01% 0.00% 22.28% 47.24%
Utilities
0.00% 0.00% 0.00% 38.58%
Real Estate
0.00% 0.00% 5.81% 44.09%
Industrials
0.00% 0.00% 3.11% 56.69%
Financial Services
0.00% 0.00% 5.48% 48.03%
Energy
0.00% 0.00% 0.31% 41.73%
Communication Services
0.00% 0.00% 2.11% 39.37%
Consumer Defense
0.00% 0.00% 33.15% 50.39%
Consumer Cyclical
0.00% 0.00% 5.27% 47.24%
Basic Materials
0.00% 0.00% 1.68% 60.63%

Stock Geographic Breakdown

Weighting Return Low Return High JFNCX % Rank
US
78.25% 59.25% 99.76% 70.08%
Non US
18.86% 0.00% 40.06% 29.92%

Bond Sector Breakdown

Weighting Return Low Return High JFNCX % Rank
Cash & Equivalents
0.88% 0.01% 9.79% 71.19%
Corporate
0.33% 0.00% 21.46% 27.12%
Derivative
0.00% -0.08% 0.00% 32.20%
Securitized
0.00% 0.00% 0.00% 37.29%
Municipal
0.00% 0.00% 0.00% 37.29%
Government
0.00% 0.00% 0.20% 38.14%

Bond Geographic Breakdown

Weighting Return Low Return High JFNCX % Rank
US
0.16% 0.00% 19.07% 4.72%
Non US
0.00% 0.00% 3.76% 40.94%

JFNCX - Expenses

Operational Fees

JFNCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.75% 0.10% 4.94% 28.21%
Management Fee 0.64% 0.09% 1.30% 44.09%
12b-1 Fee 1.00% 0.00% 1.00% 81.94%
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

JFNCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load 1.00% 1.00% 5.00% 45.83%

Trading Fees

JFNCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.75% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

JFNCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 46.00% 0.00% 341.00% 67.80%

JFNCX - Distributions

Dividend Yield Analysis

JFNCX Category Low Category High JFNCX % Rank
Dividend Yield 0.00% 0.00% 4.42% 51.18%

Dividend Distribution Analysis

JFNCX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

JFNCX Category Low Category High JFNCX % Rank
Net Income Ratio -0.74% -2.24% 1.48% 80.34%

Capital Gain Distribution Analysis

JFNCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

JFNCX - Managers

Andrew Acker

Manager

Start Date

Tenure

Tenure Rank

May 01, 2007

12.42

12.4%

Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation.


Tenure Analysis

Category Low

0.34

Category High

22.05

Category Average

9.62

Category Mode

19.43